Kephera Diagnostics awarded $3 million NIH grant for a new rapid test for Chagas disease
Framingham, MA – April 3, 2023. The National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health (NIH), has awarded a Phase II, $3,050,000 Small Business Innovative Research (SBIR) grant to Kephera Diagnostics to complete the development of a new rapid, point-of-care test for Chagas disease, the company announced…